| Name |
Noradrenalin Ligula Pharma 0,5 mg/ml koncentrat za otopinu za infuziju |
| Marketing Authorisation Number |
HR-H-288554529 |
| Active Substance |
noradrenalintartarat (norepinefrintartarat) |
| Composition |
1 ml koncentrata za otopinu za infuziju sadrži 0,5 mg noradrenalina (norepinefrina) što odgovara 1 mg noradrenalintartarata |
| Pharmaceutical Form |
koncentrat za otopinu za infuziju |
| Manufacturer |
Laboratorios Normon S.A., Tres Cantos – Madrid, Španjolska |
| Marketing Authorisation Holder |
Ligula Pharma d.o.o., Iblerov trg 7, Zagreb, Hrvatska |
| Marketing Authorisation Date |
18.01.2019 |
| MA Period of Validity |
18.01.2024 |
| Classification Number |
UP/I-530-09/17-01/27 |
| Registration Number |
381-12-01/70-19-15 |
| Prescription |
na recept |
| Type of prescription |
ograničeni recept
|
| Distribution |
u ljekarni |
| Advertising to general public |
zabranjeno |
| ATC Code |
C01CA03 |
| Medicinal product marketed in the Croatia |
Da |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
| Summary of risk management plan |
download |
